Marijuana Stocks & Public Companies

Marijuana Business Stock Ticker

Chris Walsh  | April 30, 2015
More than 100 marijuana stocks are currently listed on NASDAQ. Click to see our chart of the most relevant ones.

Canadian MJ Grower to List on Major Stock Exchange

Omar Sacirbey  | July 27, 2016

In what could be a first in both the cannabis industry and stock market history, a large marijuana cultivation company will list on a major North American stock exchange.

Canopy Growth Corp., one of Canada’s biggest licensed medical marijuana companies, started trading on the Toronto Stock Exchange (TMX) Tuesday under the ticker symbol …

Australian MMJ Company Aims to Raise $4M for Human Trials

Omar Sacirbey  | July 18, 2016

A publicly traded Australian pharmaceutical and biotech company that recently entered the medical marijuana sector aims to raise about $4.1 million (AUS $5.4 million) to support MMJ trials on human subjects.

If successful, Medlab Clinical plans to spend the money to accelerate a program of human trials of cannabis-based pain management therapy for …

Week in Review: California is Official, GW’s Epilepsy Drug & Illinois Resignation

John Schroyer  | July 1, 2016

By Omar Sacirbey and John Schroyer

California’s recreational marijuana campaign makes the November ballot, GW Pharmaceuticals’ MJ-based epilepsy drug could play a role in DEA rescheduling, and a possible new dawn in Illinois’ medical cannabis program.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Medical Cannabis Company GW Pharma’s Stock Again Jumps

John Schroyer  | June 27, 2016

GW Pharmaceuticals – a publicly traded British medical cannabis company conducting clinical trials to determine how effective its medications are against epilepsy – watched its stock surge once again in response to a successful round of testing.

News Monday that a phase 3 trial was helpful at treating patients with Lennox-Gastaut Syndrome, a type …

Chart of the Week: Monthly Recreational Marijuana Sales in U.S. Averaging $124M

Chris Walsh  | June 27, 2016

By Eli McVey

Colorado, Oregon and Washington State are averaging a combined $123.5 million in monthly recreational marijuana sales so far this year, putting the industry on pace to rack up at least $1.5 billion in adult-use cannabis revenue at the retail level in 2016.

Week in Review: OH Lawmakers Okay MMJ, Nasdaq says No to MassRoots & MMJ for Vets

John Schroyer  | May 27, 2016

By John Schroyer and Omar Sacirbey

Ohio lawmakers pass a medical marijuana bill in a bid to undercut a ballot measure, MassRoots’ Nasdaq listing is nixed again, and Congress moves to give military veterans easier access to medical cannabis.

Here’s a closer look at several notable developments in the marijuana industry over the past week.

Nasdaq Shoots Down MassRoots for Stock Listing

John Schroyer  | May 24, 2016

Denver-based MassRoots, the popular social network for cannabis enthusiasts, failed again to secure a public listing on the Nasdaq, a setback for marijuana companies hoping to trade on a major U.S. stock market.

MassRoots said in a press release the Nasdaq linked its decision to the argument that the company, as a pro-marijuana business, could be …

AmeriCann Invests $6.7M in Massachusetts MJ Facilities

Omar Sacirbey  | April 14, 2016

AmeriCann, a Denver medical marijuana company, is investing nearly $7 million in a dispensary and a grow facility in two southern coastal Massachusetts towns, according to the Taunton Gazette.

The cultivation technology and real estate company is under contract to purchase a nearly 1 million-square-foot site for a medical marijuana grow and processing facility …